Publisher： Bentham Science Publishers
E-ISSN： 2212-3873|7|1|29-34
ISSN： 1871-5303
Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.7, Iss.1, 2007-03, pp. : 29-34
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Use of the Inhibitory Receptors for Modulating the Immune Responses
Current Pharmaceutical Design, Vol. 14, Iss. 26, 2008-09 ,pp. :
Access to resources
Recommend
Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition
Current Pharmaceutical Design, Vol. 19, Iss. 22, 2013-01 ,pp. :
The Proteasome in Health and Disease
Current Pharmaceutical Design, Vol. 19, Iss. 6, 2013-02 ,pp. :
Proteasome Inhibition as a New Therapeutic Principle in Hematological Malignancies
Current Drug Targets, Vol. 7, Iss. 10, 2006-10 ,pp. :